Archean Chemical Industries growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+3.8%−21.7%−7.7%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−24.0%−32.1%−27.0%
−37.9%−40.2%−30.6%
−35.0%−49.2%−16.6%
−34.0%−49.3%−25.3%
+11.3%+16.4%+17.1%
+3.7%+9.5%+18.9%
−20.8%−53.5%−23.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ACI₹454.40

Archean Chemical Industries Ltd.

· Chemicals
₹ CrorePeersNEOGENAETHERALKYLAMINEBALAMINESTECILCHEMELLENGHCLGNFCMcap ₹5,610 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue Growth—-7.7-21.7+3.8—
EBITDA Growth—-27.0-32.1-24.0—
EBIT Growth—-30.6-40.2-37.9—
Net Income Growth—-16.6-49.2-35.0—
EPS Growth—-25.3-49.3-34.0—
Total Assets Growth—+17.1+16.4+11.3—
Total Equity Growth—+18.9+9.5+3.7—
Cash from Operations Growth—-23.5-53.5-20.8—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.